1. Hims & Hers Health, Inc. (HIMS) reported $1.5 billion in revenue in 2024, with a 69% year-over-year increase and $126 million in GAAP net income. 2. The company's subscriber base reached 2.2 million, growing 45% year-over-year, with 55% of subscribers using at least one personalized treatment. 3. Hims & Hers' GLP-1 weight loss treatments contributed $225 million in incremental revenue, but regulatory and supply risks remain significant concerns.
Related Articles
- Meta's Valuation Doesn't Add Up2 months ago
- Lululemon Q4 2024 Earnings Update2 months ago
- Palantir: It's Like Nvidia In 2022 (Rating Upgrade)2 months ago
- Nvidia Is About To Explode: Buy The Dip Or Regret It Forever2 months ago
- Grab: A Great International Diversification Play (Rating Upgrade)2 months ago
- Micron Q2: Anticipating More HBM Shipment In H22 months ago
- Nvidia: Why I Am Buying The Meltdown2 months ago
- Top Ten Chip Vendors 20242 months ago
- Why Nebius Is A High-Conviction Play2 months ago
- Bestech Micro Revenue Soars, Losses for Two Years, R&D Investment as 'Culprit'?2 months ago